Number of the records: 1  

A novel and efficient one-pot synthesis of symmetrical diamide (bis-amidate) prodrugs of acyclic nucleoside phosphonates and evaluation of their biological activities

  1. 1.
    SYSNO ASEP0363152
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleA novel and efficient one-pot synthesis of symmetrical diamide (bis-amidate) prodrugs of acyclic nucleoside phosphonates and evaluation of their biological activities
    Author(s) Jansa, Petr (UOCHB-X) RID
    Baszczyňski, Ondřej (UOCHB-X) RID, ORCID
    Dračínský, Martin (UOCHB-X) RID, ORCID
    Votruba, Ivan (UOCHB-X) RID
    Zídek, Zdeněk (UEM-P)
    Bahador, G. (US)
    Stepan, G. (US)
    Cihlar, T. (US)
    Mackman, R. (US)
    Holý, Antonín (UOCHB-X)
    Janeba, Zlatko (UOCHB-X) RID, ORCID
    Number of authors11
    Source TitleEuropean Journal of Medicinal Chemistry. - : Elsevier - ISSN 0223-5234
    Roč. 46, č. 9 (2011), s. 3748-3754
    Number of pages7 s.
    Languageeng - English
    CountryFR - France
    Keywordsprodrugs ; phosphonodiamides ; bis-amidates ; acyclic nucleoside phosphonates ; GS-9219
    Subject RIVCC - Organic Chemistry
    R&D ProjectsVG20102015046 GA MV - Ministry of Interior (MV)
    CEZAV0Z40550506 - UOCHB-X (2005-2011)
    AV0Z50390703 - UEM-P (2007-2013)
    UT WOS000295237400022
    DOI10.1016/j.ejmech.2011.05.040
    AnnotationA novel and efficient method for the one-pot synthesis of diamide (bis-amidate) prodrugs of acyclic nucleoside phosphonates, starting from free phosphonic acids or phosphonate diesters is reported. The methodology has been applied to the synthesis of the potent anticancer agent GS-9219, and symmetrical bis-amidates of other biologically active phosphonic acids.
    WorkplaceInstitute of Organic Chemistry and Biochemistry
    Contactasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Viktorie Chládková, Tel.: 232 002 434
    Year of Publishing2012
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.